EHJ - Cardiovascular Pharmacotherapy

Focusing on clinical cardiovascular pharmacology

  • Years
  • Topics
  • Special Options

Showing 24 of 888 results

Universal evidence and contextual pharmacotherapy
ESC Journals
Universal evidence and contextual pharmacotherapy
22 September 2026
See more
Response to Lu Li and colleagues
ESC Journals
Response to Lu Li and colleagues
1 September 2026
See more
Clinical and experimental insights into hydroxychloroquine-associated electrical abnormalities and cardiomyopathy
ESC Journals
Clinical and experimental insights into hydroxychloroquine-associated electrical abnormalities and cardiomyopathy
25 August 2026
See more
Emerging therapies and evolving paradigms in cardiovascular pharmacotherapy
ESC Journals
Emerging therapies and evolving paradigms in cardiovascular pharmacotherapy
17 August 2026
See more
Pharmacokinetics in the Fontan circulation: a multi-organ puzzle
ESC Journals
Pharmacokinetics in the Fontan circulation: a multi-organ puzzle
10 August 2026
See more
May the universal truth rest in peace and us with her? On how to understand inconsistency in and among pharmacological trials
ESC Journals
May the universal truth rest in peace and us with her? On how to understand inconsistency in and among pharmacological trials
5 August 2026
See more
Correction to: Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio–renal–metabolic risk modulation
ESC Journals
Correction to: Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio–renal–metabolic risk modulation
28 July 2026
See more
From ‘bridging specialties’ to ‘owning the patient’: rethinking accountability in Cardiovascular-Kidney-Metabolic syndrome care
ESC Journals
From ‘bridging specialties’ to ‘owning the patient’: rethinking accountability in Cardiovascular-Kidney-Metabolic syndrome care
27 July 2026
See more
Beyond API-CAT: the remaining challenges of extended anticoagulation for cancer-associated thrombosis
ESC Journals
Beyond API-CAT: the remaining challenges of extended anticoagulation for cancer-associated thrombosis
22 July 2026
See more
Reply to Zhang and Lou: beta-blockers after myocardial infarction should be guided by indication, ejection fraction, and contemporary evidence
ESC Journals
Reply to Zhang and Lou: beta-blockers after myocardial infarction should be guided by indication, ejection fraction, and contemporary evidence
17 July 2026
See more
Treatment effects in contemporary cardiovascular pharmacotherapy: determinants and interpretation
ESC Journals
Treatment effects in contemporary cardiovascular pharmacotherapy: determinants and interpretation
14 July 2026
See more
Bleeding risk assessment in patients with new-onset atrial fibrillation after coronary surgery (reply)
ESC Journals
Bleeding risk assessment in patients with new-onset atrial fibrillation after coronary surgery (reply)
9 July 2026
See more
The anticoagulation dilemma in post-operative atrial fibrillation after cardiac surgery
ESC Journals
The anticoagulation dilemma in post-operative atrial fibrillation after cardiac surgery
7 July 2026
See more
Bleeding risk assessment in coronary artery bypass grafting-related postoperative atrial fibrillation: clinical interpretation and future directions
ESC Journals
Bleeding risk assessment in coronary artery bypass grafting-related postoperative atrial fibrillation: clinical interpretation and future directions
6 July 2026
See more
A bleeding score identifies who bleeds, not who benefits: anticoagulation decisions in post-operative atrial fibrillation after coronary surgery
ESC Journals
A bleeding score identifies who bleeds, not who benefits: anticoagulation decisions in post-operative atrial fibrillation after coronary surgery
2 July 2026
See more
Statin adherence among patients with hypertension in Swedish primary health care: a QregPV cohort study using explainable machine learning
ESC Journals
Statin adherence among patients with hypertension in Swedish primary health care: a QregPV cohort study using explainable machine learning
29 June 2026
See more
The OCEANIC trial journey: from failure to breakthrough?
ESC Journals
The OCEANIC trial journey: from failure to breakthrough?
27 June 2026
See more
Why cardio-rheumatology?
ESC Journals
Why cardio-rheumatology?
26 June 2026
See more
API-CAT investigators’ decisions on anticoagulation following extended treatment for cancer-associated thrombosis Clinical decisional uncertainty in extended anticoagulation for cancer-associated Thrombosis: the investigators' view before practice-changing evidence from the API-CAT trial
ESC Journals
API-CAT investigators’ decisions on anticoagulation following extended treatment for cancer-associated thrombosis Clinical decisional uncertainty in extended anticoagulation for cancer-associated Thrombosis: the investigators' view before practice-changing evidence from the API-CAT trial
26 June 2026
See more
Semaglutide for primary prevention of major adverse cardiac and cerebrovascular events in patients with type 2 diabetes and comorbid rheumatoid arthritis: a target-trial emulation
ESC Journals
Semaglutide for primary prevention of major adverse cardiac and cerebrovascular events in patients with type 2 diabetes and comorbid rheumatoid arthritis: a target-trial emulation
23 June 2026
See more
Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio–renal–metabolic risk modulation
ESC Journals
Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio–renal–metabolic risk modulation
17 June 2026
See more
Bleeding risk assessment in patients with new-onset atrial fibrillation after coronary surgery: a proof-of-concept study
ESC Journals
Bleeding risk assessment in patients with new-onset atrial fibrillation after coronary surgery: a proof-of-concept study
16 June 2026
See more
Beta-blockers after myocardial infarction: indication, ejection fraction, and de-escalation pathway
ESC Journals
Beta-blockers after myocardial infarction: indication, ejection fraction, and de-escalation pathway
13 June 2026
See more
Longitudinal loop diuretic use in patients with HFrEF initiated with sodium–glucose cotransporter 2 inhibitors
ESC Journals
Longitudinal loop diuretic use in patients with HFrEF initiated with sodium–glucose cotransporter 2 inhibitors
10 June 2026
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources